Benzinga | Mar 11, 2021 07:07AM EST

Bicycle Therapeutics Q4 EPS $(0.83) Down From $(0.25) YoY, Sales $3.85M Down From $5.28M YoY

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.83) per share. This is a 232 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $3.85 million in sales this quarter. This is a 27.14 percent decrease over sales of $5.28 million the same period last year.